Literature DB >> 15783263

Cholesterol, statins, and Alzheimer disease.

Alexei R Koudinov, Temirbolat T Berezov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15783263      PMCID: PMC1069670          DOI: 10.1371/journal.pmed.0020081

Source DB:  PubMed          Journal:  PLoS Med        ISSN: 1549-1277            Impact factor:   11.069


× No keyword cloud information.
After reading the excellent research article by Pedrini et al. [1] and the associated synopsis [2], one may conclude that the only pathway of statins' effect on Alzheimer disease (AD) is the regulation of amyloid precursor protein (APP) processing and amyloid-ß protein (Aß) generation. The moderation is provided in the research article's patient summary, reminding that “statins are likely to influence the risk for Alzheimer disease by several different pathways.” What are these other pathways? It is essential to note that in addition to APP processing and Aß chemistry being modulated by statins, fine tuning of cholesterol homeostasis also affects cholinergic function, ionotropic and metabotropic receptors, tau phosphorylation, neural oxidative stress reactions, and other features of neurodegeneration (reviewed in [3]). Moreover, precise regulation of neural cholesterol dynamics and supply is itself essential for synapse function, plasticity, and behaviour [3]. These data suggest that in addition to its role in sporadic AD, cholesterol homeostasis break is the unifying primary cause of neuromuscular diseases, Niemann-Pick type C disease, and Down syndrome, and explains why rare cases of familial AD (associated with mutations in APP and presenilin genes) are translated into Alzheimer's via membrane cholesterol sensitivity of APP processing by secretases and Aß generation. Also important, is the synopsis's [2] apparently outdated dividing of APP processing into “harmful” (Aß-generating) and “healthy” (non-amyloidogenic). One should be cautious in calling Aß a harmful molecule. This is because several recent studies have illuminated an essential function for amyloidogenic processing of APP and Aß in neurons [4] and synapses [5]. In this context, the reciprocal effect of Aß on cholesterol synthesis, cellular uptake, efflux, and esterification, and its relation to the experimental restoration of long-term potentiation (LTP, a synaptic plasticity measure) may represent one of the poorly comprehended physiological functions of Aß [6,7].
  5 in total

1.  The production of amyloid beta peptide is a critical requirement for the viability of central neurons.

Authors:  Leigh D Plant; John P Boyle; Ian F Smith; Chris Peers; Hugh A Pearson
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

Review 2.  Cholesterol homeostasis failure as a unifying cause of synaptic degeneration.

Authors:  Alexei R Koudinov; Natalia V Koudinova
Journal:  J Neurol Sci       Date:  2004-12-16       Impact factor: 3.181

3.  APP processing and synaptic function.

Authors:  Flavio Kamenetz; Taisuke Tomita; Helen Hsieh; Guy Seabrook; David Borchelt; Takeshi Iwatsubo; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

Review 4.  Alzheimer's amyloid-beta (A beta) is an essential synaptic protein, not neurotoxic junk.

Authors:  Alexei R Koudinov; Temirbolat T Berezov
Journal:  Acta Neurobiol Exp (Wars)       Date:  2004       Impact factor: 1.579

5.  Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK.

Authors:  Steve Pedrini; Troy L Carter; George Prendergast; Suzana Petanceska; Michelle E Ehrlich; Sam Gandy
Journal:  PLoS Med       Date:  2005-01-11       Impact factor: 11.069

  5 in total
  4 in total

1.  Apolipoprotein E and cholesterol in aging and disease in the brain.

Authors:  Elena Posse de Chaves; Vasanthy Narayanaswami
Journal:  Future Lipidol       Date:  2008-10

Review 2.  Lipid metabolism in Alzheimer's disease.

Authors:  Qiang Liu; Juan Zhang
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

3.  Cholesterol tuning of BK ethanol response is enantioselective, and is a function of accompanying lipids.

Authors:  Chunbo Yuan; Maohui Chen; Douglas F Covey; Linda J Johnston; Steven N Treistman
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

4.  Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.

Authors:  Leonel Rojo; Marcela K Sjöberg; Paula Hernández; Cristian Zambrano; Ricardo B Maccioni
Journal:  J Biomed Biotechnol       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.